Medica Sur SA de CV

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MXP510121215
MXN
56.00
-1 (-1.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
4,402.82
4,129.75
3,867.92
3,812.20
4,466.19
3,698.07
3,607.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,402.82
4,129.75
3,867.92
3,812.20
4,466.19
3,698.07
3,607.61
Raw Material Cost
2,946.03
2,702.99
2,500.74
2,308.24
2,798.43
2,605.49
2,496.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
123.76
119.63
75.95
76.83
186.04
173.11
144.59
Selling and Distribution Expenses
774.08
791.48
792.25
757.28
679.65
732.53
730.06
Other Expenses
-12.38
-11.96
-7.59
-7.68
-18.60
-17.31
-14.46
Total Expenditure (Excl Depreciation)
3,720.11
3,494.46
3,292.99
3,065.52
3,478.08
3,338.03
3,226.64
Operating Profit (PBDIT) excl Other Income
682.6999999999999
635.3
574.9
746.7
988.1
360
381
Other Income
104.23
195.17
178.05
61.93
-6.07
10.23
27.36
Operating Profit (PBDIT)
986.51
1,039.75
924.72
957.67
1,302.28
721.14
629.21
Interest
123.76
119.63
75.95
76.83
186.04
173.11
144.59
Exceptional Items
-74.42
0.00
-4.30
-100.58
-1.15
0.00
0.00
Gross Profit (PBDT)
1,456.79
1,426.77
1,367.18
1,503.96
1,667.76
1,092.57
1,111.03
Depreciation
194.18
178.62
166.89
166.80
323.77
350.87
220.88
Profit Before Tax
594.15
741.51
677.58
613.46
791.32
197.16
263.74
Tax
171.68
183.61
204.79
255.88
232.47
56.60
107.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
422.47
557.90
472.79
357.61
558.83
140.55
156.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
422.47
557.90
472.79
357.61
558.83
140.55
156.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-0.03
0.02
0.02
0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
422.47
557.90
472.79
357.58
558.85
140.57
156.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,343.04
2,036.23
2,521.32
4,913.34
4,007.88
3,681.51
3,542.40
Earnings per share (EPS)
5.28
6.94
5.18
3.22
4.94
1.14
1.27
Diluted Earnings per share
5.28
6.94
5.18
3.22
4.94
1.14
1.27
Operating Profit Margin (Excl OI)
15.63%
16.13%
14.99%
19.12%
22.05%
9.74%
10.56%
Gross Profit Margin
17.91%
22.28%
21.83%
20.47%
24.97%
14.82%
13.43%
PAT Margin
9.6%
13.51%
12.22%
9.38%
12.51%
3.8%
4.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 6.61% vs 6.77% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -24.27% vs 18.00% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 4.46% vs 13.11% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 3.51% vs 57.58% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Medica Sur SA de CV With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(MXN)
Change(%)
Net Sales
4,402.82
0
4,402.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,402.82
0
4,402.82
Raw Material Cost
2,946.03
0
2,946.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
123.76
0
123.76
Selling and Distribution Expenses
774.08
0
774.08
Other Expenses
-12.38
0.00
-12.38
Total Expenditure (Excl Depreciation)
3,720.11
0
3,720.11
Operating Profit (PBDIT) excl Other Income
682.71
0.00
682.71
Other Income
104.23
0
104.23
Operating Profit (PBDIT)
986.51
0
986.51
Interest
123.76
0
123.76
Exceptional Items
-74.42
0
-74.42
Gross Profit (PBDT)
1,456.79
0
1,456.79
Depreciation
194.18
0
194.18
Profit Before Tax
594.15
0
594.15
Tax
171.68
0
171.68
Provisions and contingencies
0
0
0.00
Profit After Tax
422.47
0
422.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
422.47
0
422.47
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
422.47
0
422.47
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
2,343.04
0
2,343.04
Earnings per share (EPS)
5.28
0
5.28
Diluted Earnings per share
5.28
0
5.28
Operating Profit Margin (Excl OI)
15.63%
0%
0.00
15.63%
Gross Profit Margin
17.91%
0%
0.00
17.91%
PAT Margin
9.60%
0%
0.00
9.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 440.28 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.61% vs 6.77% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 42.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -24.27% vs 18.00% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 88.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.46% vs 13.11% in Dec 2023

Annual - Interest
Interest 12.38 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.51% vs 57.58% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.63%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023